Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

107
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
107

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations Between Socioeconomic Status and Adult Congenital Heart Disease Mortality in the United States: Insights From the Global Burden of Disease Study.

Journal of the American Heart Association·2026
Same author

Trigger Criteria for Advance Care Planning in Adults With Congenital Heart Disease: A Systematic Review.

CJC pediatric and congenital heart disease·2026
Same author

Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).

JACC. Advances·2026
Same author

High Intensity Interval Training Versus Moderate Continuous Training in Adults with Congenital Heart Disease: A Randomized Controlled Trial.

The Canadian journal of cardiology·2026
Same author

The Association of Single Ventricle Morphology with Long Term Quality of Life Among Survivors: A Report from CHD PULSE (Congenital Heart Disease Project to Understand Lifelong Survivor Experience).

American heart journal·2026
Same author

Design and Implementation of My Health, My Heart: A Pilot Healthcare Transition Program for Adolescents with Congenital Heart Disease.

Pediatric cardiology·2026

Related Experiment Video

Updated: Jul 25, 2025

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.5K

The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis.

David J Goldberg1, Chenwei Hu2, Adam M Lubert3

  • 1Division of Cardiology, The Children's Hospital of Philadelphia, Perelman School of Medicine, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA. goldbergda@chop.edu.

Pediatric Cardiology
|June 29, 2023
PubMed
Summary

Udenafil improved exercise capacity in Fontan patients, with benefits observed across various subgroups. This suggests potential widespread efficacy, warranting further investigation into long-term effects and safety.

Keywords:
ExerciseFontanUdenafil

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.4K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

7.9K

Related Experiment Videos

Last Updated: Jul 25, 2025

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.5K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.4K
Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

7.9K

Area of Science:

  • Pediatric Cardiology
  • Exercise Physiology
  • Pharmacology

Background:

  • The Fontan circulation presents unique challenges for exercise capacity.
  • Udenafil has shown potential to improve exercise performance in these patients.
  • Identifying patient subgroups that benefit most is crucial for targeted therapy.

Purpose of the Study:

  • To conduct a post hoc analysis of the FUEL trial.
  • To evaluate differential effects of udenafil on exercise performance in subgroups of Fontan patients.
  • To assess treatment response based on baseline characteristics.

Main Methods:

  • Subgroup analyses based on peak oxygen consumption (VO2), BNP, weight, race, gender, and ventricular morphology.
  • ANCOVA modeling to assess treatment arm, subgroup, and interaction effects.
  • Evaluation of exercise parameters including peak VO2, work rate at ventilatory anaerobic threshold (VAT), and ventilatory efficiency (VE/VCO2).

Main Results:

  • Trends toward improved peak VO2, work rate at VAT, VO2 at VAT, and VE/VCO2 with udenafil across most subgroups.
  • No significant differential response identified based on baseline characteristics.
  • Participants with lower baseline peak VO2 showed a trend towards greater improvement.

Conclusions:

  • Udenafil demonstrated consistent, albeit trending, improvements in exercise parameters across diverse Fontan patient subgroups.
  • The lack of a differential response suggests broad applicability of udenafil's benefits.
  • Further research is needed to confirm efficacy, assess long-term safety, and evaluate impact on Fontan-associated morbidities.